Background: Assessment of potential geographic variation in quality indicators of atrial
fibrillation care may identify opportunities for improvement in the quality of atrial fibrillation …

Importance Black and Hispanic patients are less likely than white patients to use oral
anticoagulants for atrial fibrillation. Little is known about racial/ethnic differences in use of …

Objective In patients with newly diagnosed atrial fibrillation (AF), do baseline risk factors and
stroke prevention strategies account for the geographically diverse outcomes. Design Global …

Aim To explore the potential of small-area variation analysis as a tool for identifying
unwarranted variation in oral anticoagulation (OAC) use and clinical outcomes in patients …

A multidimensional approach involving consideration of available resources, individual
patient characteristics, patient preferences, and cost of treatment is often required to …

Background: Atrial fibrillation (AF) accounts for substantial resource utilization that is
expected to increase as the US population ages. Management strategies for AF vary widely …

BACKGROUND: Warfarin is recommended for prevention of stroke in patients with atrial
fibrillation who are at moderate or high risk, but requires intensive management to achieve …

Little is known about differences in practice patterns or outcomes in the management of
patients who have atrial fibrillation in Canada compared with those in the United States …

Background Geographical mapping of variations in the treatment and outcomes of a disease
is a valuable tool for identifying inequity. We examined international and intranational …

Oral anticoagulants (OACs) have been used to prevent stroke/systemic embolism (SE)
among patients with non-valvular atrial fibrillation (NVAF). To evaluate baseline clinical …